Marie Scully Selected Research

Thrombotic Thrombocytopenic Purpura

1/2022	Alterations in B- and circulating T-follicular helper cell subsets in immune thrombotic thrombocytopenic purpura.
1/2022	European Renal Best Practice endorsement of guidelines for diagnosis and therapy of thrombotic thrombocytopaenic purpura published by the International Society on Thrombosis and Haemostasis.
1/2022	The use of obinutuzumab and ofatumumab in the treatment of immune thrombotic thrombocytopenic purpura.
12/2021	How to evaluate and treat the spectrum of TMA syndromes in pregnancy.
1/2021	Novel antiplatelet strategies targeting VWF and GPIb.
1/2021	Real-world experience with caplacizumab in the management of acute TTP.
1/2021	Redefining outcomes in immune TTP: an international working group consensus report.
12/2020	Cerebral MRI findings predict the risk of cognitive impairment in thrombotic thrombocytopenic purpura.
11/2020	Management of thrombotic microangiopathy in pregnancy and postpartum: report from an international working group.
10/2020	Clinical outcomes and risk factors for severe COVID-19 in patients with haematological disorders receiving chemo- or immunotherapy.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Marie Scully Research Topics

Disease

41	Thrombotic Thrombocytopenic Purpura 01/2022 - 10/2006
14	Thrombocytopenia (Thrombopenia) 12/2022 - 03/2014
13	Thrombosis (Thrombus) 12/2022 - 01/2016
13	Thrombotic Microangiopathies 06/2021 - 01/2014
10	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 01/2022 - 11/2015
8	acquired Thrombotic thrombocytopenic purpura 01/2022 - 08/2011
7	COVID-19 12/2022 - 01/2020
6	Atypical Hemolytic Uremic Syndrome 06/2021 - 10/2016
5	Hemorrhage 01/2021 - 02/2016
4	Infections 12/2022 - 08/2011
4	Purpura 01/2022 - 09/2006
4	Hemolytic-Uremic Syndrome 12/2021 - 01/2017
4	Hemolysis 12/2021 - 10/2018
3	Pre-Eclampsia (Preeclampsia) 12/2021 - 10/2018
3	Chronic Kidney Failure (Chronic Renal Failure) 10/2021 - 01/2018
3	Headache (Headaches) 12/2020 - 11/2019
3	Stroke (Strokes) 11/2019 - 09/2006
3	Disseminated Intravascular Coagulation 01/2019 - 01/2017
2	Serum Sickness 01/2022 - 01/2019
2	Anaphylaxis (Anaphylactic Shock) 01/2022 - 01/2018
2	Venous Thrombosis (Deep-Vein Thrombosis) 01/2022 - 01/2021
2	Intracranial Sinus Thrombosis (Sinus Thrombosis) 10/2021 - 09/2021
2	Neoplasms (Cancer) 10/2020 - 01/2019
2	Disease Progression 10/2020 - 01/2020
2	Ischemic Stroke 01/2020 - 01/2015
2	Hemolytic Anemia 01/2019 - 03/2014
2	Sepsis (Septicemia) 01/2019 - 01/2017
1	Severe Acute Respiratory Syndrome 01/2022
1	Rare Diseases (Rare Disease) 01/2022
1	Hypersensitivity (Allergy) 01/2022
1	Pregnancy-Induced Hypertension (Hypertension, Pregnancy Induced) 12/2021
1	Acute Kidney Injury (Acute Renal Failure) 06/2021
1	Chronic Renal Insufficiency 06/2021
1	Cerebrovascular Disorders (Cerebrovascular Occlusion) 01/2021
1	Eclampsia 11/2020
1	Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome) 11/2020
1	Bone Marrow Failure Disorders 10/2020
1	Transient Ischemic Attack 01/2020
1	Brain Injuries (Brain Injury) 01/2020
1	Epistaxis (Nosebleed) 01/2020
1	Autoimmune Diseases (Autoimmune Disease) 11/2019
1	Abdominal Pain (Pain, Abdominal) 11/2019
1	Lethargy 11/2019
1	Ovarian Neoplasms (Ovarian Cancer) 03/2019
1	Ischemia 01/2019
1	Brain Ischemia (Cerebral Ischemia) 01/2019

Drug/Important Bio-Agent (IBA)

34	thiamine triphosphorate (TTP)IBA 01/2022 - 09/2006
11	VaccinesIBA 12/2022 - 01/2021
9	AntibodiesIBA 01/2022 - 02/2007
9	Rituximab (Mabthera)FDA Link 01/2022 - 02/2007
8	Complement System Proteins (Complement)IBA 12/2021 - 03/2014
7	von Willebrand FactorIBA 12/2022 - 01/2015
7	caplacizumabIBA 01/2022 - 02/2016
6	ChAdOx1 nCoV-19IBA 12/2022 - 01/2021
6	DisintegrinsIBA 11/2019 - 02/2007
6	ThrombospondinsIBA 11/2019 - 02/2007
6	Metalloproteases (Metalloproteinases)IBA 11/2019 - 02/2007
5	AntigensIBA 12/2022 - 02/2007
5	EnzymesIBA 01/2022 - 10/2018
5	fibrin fragment D (D-dimer)IBA 01/2022 - 01/2021
5	Inosine Triphosphate (ITP)IBA 01/2022 - 11/2015
5	Heparin (Liquaemin)FDA LinkGeneric 01/2022 - 01/2016
5	AutoantibodiesIBA 01/2021 - 02/2007
4	Immunoglobulin G (IgG)IBA 01/2022 - 02/2007
4	ravulizumabIBA 06/2021 - 01/2020
4	Complement Inactivating AgentsIBA 05/2021 - 10/2018
3	Platelet Factor 4IBA 01/2022 - 01/2021
3	eculizumab FDA Link 10/2021 - 01/2018
2	ofatumumab FDA Link 01/2022 - 01/2018
2	Monoclonal AntibodiesIBA 01/2022 - 11/2019
2	Factor VIII (Coagulation Factor VIII)IBA 01/2022 - 10/2006
2	Fibrinogen (Factor I)FDA Link 01/2022 - 10/2021
2	Complement C5 (Complement 5)IBA 10/2021 - 06/2021
2	AnticoagulantsIBA 01/2021 - 01/2016
2	Intravenous Immunoglobulins (IVIG)FDA Link 11/2019 - 12/2018
2	Dacarbazine (DIC)FDA LinkGeneric 01/2019 - 01/2018
2	Blood Coagulation Factors (Coagulation Factor)IBA 01/2019 - 01/2018
2	Mycophenolic Acid (Cellcept)FDA LinkGeneric 12/2018 - 11/2015
2	Complement C3a (Complement 3a)IBA 10/2016 - 03/2014
1	BNT162 VaccineIBA 01/2022
1	obinutuzumabIBA 01/2022
1	ImmunosorbentsIBA 01/2022
1	A-factor (Streptomyces)IBA 10/2021
1	COVID-19 VaccinesIBA 09/2021
1	Immunoglobulins (Immunoglobulin)IBA 01/2021
1	C-Reactive ProteinIBA 10/2020
1	Janus Kinase InhibitorsIBA 01/2020
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 01/2020
1	CreatinineIBA 01/2020
1	Biological ProductsIBA 01/2020
1	PlatinumIBA 01/2019
1	Gemcitabine FDA Link 01/2019

Therapy/Procedure

10	Therapeutics 01/2022 - 04/2012
7	Plasma Exchange 02/2021 - 02/2007
2	Catheters 01/2022 - 01/2020
1	Hemofiltration 01/2022
1	Extracorporeal Membrane Oxygenation 01/2022
1	Immunotherapy 10/2020
1	Central Venous Catheters 03/2019
1	Drug Therapy (Chemotherapy) 03/2019